Company / Operating Cash Flow per Share
NEUROONE MEDICAL TECHNOLOGIES Corp Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.36
FY2025
5-year range
-$0.72 / -$0.36
FY2021-FY2025
Trend
+33.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.72 in FY2022 to $-0.00 in FY2011.
Based on SEC 10-K filings.
-0.36 in FY2025.
Improved from $-0.46 to $-0.36 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 33.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2011.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.36 | +33.6% |
| FY2024 | -$0.54 | -16.1% |
| FY2023 | -$0.46 | +35.3% |
| FY2022 | -$0.72 | -54.6% |
| FY2021 | -$0.46 | -7674.7% |
| FY2016 | -$0.01 | -15.5% |
| FY2015 | -$0.01 | -4.3% |
| FY2014 | -$0.00 | +8.5% |
| FY2012 | -$0.01 | -377.8% |
| FY2011 | -$0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026